Group 1: IPO Applications - The China Securities Regulatory Commission (CSRC) accepted IPO applications for several companies including Dazhu CNC, Kaijie E-commerce, Shenyang Intelligent, and Hemei Pharmaceutical for listing on the Hong Kong Stock Exchange [1][3] - The report covers the period from December 1 to December 6, 2025, indicating a growing trend of domestic companies seeking overseas listings [1] Group 2: Company Profiles - Dazhu CNC specializes in PCB (Printed Circuit Board) production equipment solutions, serving various downstream industries such as server and data storage, automotive electronics, mobile phones, computers, and consumer electronics [3][4] - Kaijie E-commerce provides comprehensive and customized digital retail solutions to brand owners, enhancing their e-commerce infrastructure and driving online sales [4] - Hemei Pharmaceutical, established in 2002, focuses on discovering and developing small molecule drugs for autoimmune diseases and tumors, with expertise in Psoriasis, Behçet's Disease, and Inflammatory Bowel Disease [4] - Shenyang Intelligent is a decision-making AI technology company, ranked first in China's marketing and sales decision-making AI application market with a market share of 2.6% as of 2024 [4]
新股消息 | 大族数控(301200.SZ)、凯诘电商等拟港股IPO已获中国证监会接收材料